Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Affiliations

• ¹ Department of Oncology, Akershus University Hospital, Lørenskog; Faculty of Medicine, University of Oslo, Oslo, Norway.
• ² Department of Cellular Pathology, Barts Cancer Institute, Queen Mary University of London, London; Barts Health NHS Trust, London, UK.
• ³ Department of Oncology, Hematology, Bone Marrow Transplantation with section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁴ Fundacion Instituto Valenciano de Oncología, València, Spain.
• ⁵ Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
• ⁶ Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ⁷ Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST),'Dino Amadori', Meldola, Italy.
• ⁸ Department of Oncology, University Hospital of North Norway and UiT-The Arctic University, Tromsoe, Norway.
• ⁹ Institute of Cancer Research and Royal Marsden Foundation Trust, London, UK.
• ¹⁰ Department of Urology, Hospital de Braga, Hospital CUF Coimbra, Faculty of Medicine University of Coimbra, Coimbra, Portugal.
• ¹¹ Department of Diagnostic Radiology, Royal Marsden Hospital, Sutton, Surrey, UK.
• ¹² Oncology Institute of Southern Switzerland, EOC, Bellinzona; Faculty of Biomedical Sciences, USI, Lugano, Switzerland; Division of Cancer Medicine, University of Manchester, Manchester.
• ¹³ Barts Health NHS Trust, London, UK.